| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.6245448 |
| P953 | full work available at URL | https://syndication.highwire.org/content/doi/10.1126/science.6245448 |
| P698 | PubMed publication ID | 6245448 |
| P50 | author | Gavril W. Pasternak | Q92217073 |
| P2093 | author name string | S. H. Snyder | |
| S. R. Childers | |||
| P2860 | cites work | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| 6.beta.-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan (chloranaltrexamine), a potent opioid receptor alkylating agent with ultralong narcotic antagonist activity | Q34141607 | ||
| Chloroxymorphamine, an Opioid Receptor Site-Directed Alkylating Agent Having Narcotic Agonist Activity | Q34377850 | ||
| Endogenous opioid peptides: multiple agonists and receptors | Q34986433 | ||
| Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents | Q39313497 | ||
| Identification of novel high affinity opiate receptor binding in rat brain | Q48476166 | ||
| Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones | Q72612035 | ||
| P433 | issue | 4443 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 514-516 | |
| P577 | publication date | 1980-05-01 | |
| 1980-05-02 | |||
| P1433 | published in | Science | Q192864 |
| P1476 | title | Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors | |
| Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors | |||
| P478 | volume | 208 |
| Q34169931 | 14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile |
| Q39158190 | A "tail" of opioid receptor variants. |
| Q44330554 | A comparative study in rats of the respiratory depression and analgesia induced by μ- and δ-opioid agonists |
| Q72913920 | ACTH-induced grooming involves high-affinity opiate receptors |
| Q48536754 | Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study |
| Q49108187 | Alterations of synaptic high and low affinity opiate binding sites after acute and chronic morphine administration in mice |
| Q71809737 | Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide |
| Q35563397 | Anatomy and physiology of chronic pain |
| Q68753976 | Antagonism of morphine analgesia by nonopioid cold-water swim analgesia: direct evidence for collateral inhibition |
| Q44334055 | Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor |
| Q73190576 | Antisense mapping: assessing functional significance of genes and splice variants |
| Q44275456 | CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502. |
| Q48094185 | Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves |
| Q48643732 | Cardiovascular responses to microinjections of endomorphin-2 into the nucleus of the solitary tract are attenuated in the spontaneously hypertensive rat. |
| Q36374248 | Classification of multiple morphine and enkephalin binding sites in the central nervous system |
| Q34675455 | Clinical features and management of intoxication due to hallucinogenic drugs |
| Q79991386 | Codeine and 6-acetylcodeine analgesia in mice |
| Q40853885 | Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS. |
| Q34253888 | Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia |
| Q37170275 | Development of delta opioid peptides as nonaddicting analgesics |
| Q52297184 | Developmental differences between high and low affinity opiate binding sites: Their relationship to analgesia and respiratory depression |
| Q44333400 | Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla |
| Q44345097 | Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine |
| Q36412585 | Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography |
| Q72880466 | Differentiation of opiate receptors in the brain by the selective development of tolerance |
| Q43921681 | Effects of adrenoceptor agonists and antagonists on morphine-induced Straub tail in mice |
| Q42452233 | Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes |
| Q41533628 | Electrophysiological support in favor of multiple opiate receptors in the caudate and the central gray of the rat |
| Q40085590 | Endogenous opiates: 1980 |
| Q44352723 | Endogenous opioid systems in brain |
| Q42537695 | Endomorphins fully activate a cloned human mu opioid receptor |
| Q28295151 | Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum |
| Q33950375 | Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene |
| Q44344657 | Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing |
| Q47934009 | Genetic dissociation of morphine analgesia from hyperalgesia in mice |
| Q34671312 | Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1. |
| Q44330378 | Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. |
| Q52275773 | Kinetic behavior of a receptor-enzyme system: a model for drug addiction. |
| Q34253970 | Metkephamid (Tyr-D-Ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: Receptor binding and analgesic properties |
| Q44341747 | Micro1-opioid antagonist naloxonazine alters ethanol discrimination and consumption |
| Q38331826 | Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS. |
| Q41550189 | Morphiceptin (NH 4 -Tyr-Pro-Phe-Pro-COHN 2 ): a Potent and Specific Agonist for Morphine (μ) Receptors |
| Q70774870 | Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds |
| Q33581970 | Mu opioid receptors in pain management |
| Q37236111 | Mu opioids and their receptors: evolution of a concept |
| Q40123055 | Multiple Neurotransmitter Receptors |
| Q24613589 | Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia |
| Q72903604 | Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin |
| Q42246481 | Naloxozone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine |
| Q42391159 | New advances in analgesic and anxiolytic agents: implications for continued support of basic research |
| Q44352975 | Ontogeny of opioid pharmacology and receptors: High and low affinity site differences |
| Q48941537 | Opiate Receptors from Different Tissue Sources: Solubilization and Characterization |
| Q44353157 | Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity |
| Q72912832 | Opiates and enkephalins: A common binding site mediates their analgesic actions in rats |
| Q34250337 | Oxymorphazone: A long-acting opiate analgesic |
| Q62028952 | Perioperative anxiety: psychobiology and effects in postoperative recovery |
| Q34125112 | Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA. |
| Q52591971 | Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic. |
| Q69848797 | Quantitative autoradiographic distribution of meptazinol-sensitive binding sites in rat brain |
| Q48459094 | Quantitative autoradiography of the development of mu opiate binding sites in rat brain |
| Q28262450 | Receptor binding and analgesic properties of oxymorphazone |
| Q38254516 | Site and mechanism of morphine tolerance in the gastrointestinal tract |
| Q53816815 | Site of action of intrathecal morphine. |
| Q44353442 | Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites |
| Q72920302 | Spinal and supraspinal sites for morphine and nefopam analgesia in the mouse |
| Q37693807 | Spinal endomorphin 2 antinociception and the mechanisms that produce it are both sex- and stage of estrus cycle-dependent in rats. |
| Q34948489 | The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene |
| Q72903597 | The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2 Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand |
| Q24541287 | The analgesic activity of morphine-6-glucuronide |
| Q70217521 | The effects of chronic naloxone on pituitary hormone secretion in female rats |
| Q34333349 | The pharmacology of mu analgesics: from patients to genes |
| Q40088281 | The practical use of narcotic analgesics |
| Q52295955 | Threshold differences for naloxone and naltrexone in the hypothalamus and midbrain using fixed ratio brain self-stimulation in rats. |
| Q72878937 | μ- and δ-opiate receptors: Correlation with high and low affinity opiate binding sites |
Search more.